<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36673587</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9032</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>11</Day></PubDate></JournalIssue><Title>Healthcare (Basel, Switzerland)</Title><ISOAbbreviation>Healthcare (Basel)</ISOAbbreviation></Journal><ArticleTitle>Long COVID Symptomatology and Associated Factors in Primary Care Patients: The EPICOVID-AP21 Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">218</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/healthcare11020218</ELocationID><Abstract><AbstractText>Persistent COVID-19 condition includes a wide variety of symptoms and health problems of indeterminate duration. The present study examined the sociodemographic and clinical characteristics of the population with Long COVID seen in Primary Care using a questionnaire based on the existing scientific literature. It was an observational and descriptive study of the characteristics of the Spanish population with Long COVID over 14 years of age. The responses were analysed by means of a descriptive analysis of the variables recorded, in addition to a bivariate analysis to determine the existence of a relationship between persistent COVID-19 and variables such as gender, age, vaccination status or concomitant pathology. The results obtained clearly describe the sociodemographic characteristics of the population, highlighting the predominance of female gender and the prevalence of tiredness and fatigue. Furthermore, relevant information was obtained on the differences in symptomatology according to gender, age, previous pathologies and alterations derived from infection and/or vaccination. These data are important for better detection, diagnosis and treatment of Long COVID and the improvement of the quality of life of this population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romero-Rodr&#xed;guez</LastName><ForeName>Esperanza</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5054-3845</Identifier><AffiliationInfo><Affiliation>Maimonides Institute for Biomedical Research of C&#xf3;rdoba (IMIBIC), Reina Sof&#xed;a University Hospital, C&#xf3;rdoba University, 14004 C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multiprofessional Family and Community Care Teaching Unit of C&#xf3;rdoba, 14011 C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multiprofessional Teaching Unit for Family and Community Care, C&#xf3;rdoba and Guadalquivir Health District, 14011 C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Carlos Castilla del Pino Clinical Management Unit, 14011 C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perula-de-Torres</LastName><ForeName>Luis &#xc1;ngel</ForeName><Initials>L&#xc1;</Initials><AffiliationInfo><Affiliation>Maimonides Institute for Biomedical Research of C&#xf3;rdoba (IMIBIC), Reina Sof&#xed;a University Hospital, C&#xf3;rdoba University, 14004 C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multiprofessional Family and Community Care Teaching Unit of C&#xf3;rdoba, 14011 C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multiprofessional Teaching Unit for Family and Community Care, C&#xf3;rdoba and Guadalquivir Health District, 14011 C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Lama</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6033-9677</Identifier><AffiliationInfo><Affiliation>Maimonides Institute for Biomedical Research of C&#xf3;rdoba (IMIBIC), Reina Sof&#xed;a University Hospital, C&#xf3;rdoba University, 14004 C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Matrona Antonia Mesa Fern&#xe1;ndez" Health Center, Cabra Clinical Management Unit, AGS South of C&#xf3;rdoba, 14940 C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro-Jim&#xe9;nez</LastName><ForeName>Rafael &#xc1;ngel</ForeName><Initials>R&#xc1;</Initials><AffiliationInfo><Affiliation>Maimonides Institute for Biomedical Research of C&#xf3;rdoba (IMIBIC), Reina Sof&#xed;a University Hospital, C&#xf3;rdoba University, 14004 C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Especialista en Medicina Familiary Comunitaria, University Hospital Reina Sof&#xed;a, 14004 C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Garc&#xed;a</LastName><ForeName>Celia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Maimonides Institute for Biomedical Research of C&#xf3;rdoba (IMIBIC), Reina Sof&#xed;a University Hospital, C&#xf3;rdoba University, 14004 C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multiprofessional Teaching Unit for Family and Community Care, C&#xf3;rdoba and Guadalquivir Health District, 14011 C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Priego-P&#xe9;rez</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of C&#xf3;rdoba, 14004 C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe9;lez-Santamar&#xed;a</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5146-1398</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences, University of Burgos, 09001 Burgos, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim&#xf3;n-Vicente</LastName><ForeName>Luc&#xed;a</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, University of Burgos, 09001 Burgos, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Santos</LastName><ForeName>Josefa</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, University of Burgos, 09001 Burgos, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Bernal</LastName><ForeName>Jer&#xf3;nimo J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0002-7298-9060</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences, University of Burgos, 09001 Burgos, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Healthcare (Basel)</MedlineTA><NlmUniqueID>101666525</NlmUniqueID><ISSNLinking>2227-9032</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">admission</Keyword><Keyword MajorTopicYN="N">age</Keyword><Keyword MajorTopicYN="N">gender</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">persistent COVID</Keyword><Keyword MajorTopicYN="N">post COVID-19</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36673587</ArticleId><ArticleId IdType="pmc">PMC9858944</ArticleId><ArticleId IdType="doi">10.3390/healthcare11020218</ArticleId><ArticleId IdType="pii">healthcare11020218</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ministerio de Sanidad  Minist Sanid 2022.  [(accessed on 31 December 2021)].  Available online:  https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/situacionActual.htm.</Citation></Reference><Reference><Citation>Consilium  COVID-19: Respuesta de la UE en el &#xc1;mbito de la Salud P&#xfa;blica. 2022.  [(accessed on 23 September 2021)].  Consilium Europa. Available online:  https://www.consilium.europa.eu/es/policies/coronavirus/covid-19-public-health/</Citation></Reference><Reference><Citation>P&#xe1;rraga Mart&#xed;nez I., P&#xe9;rula de Torres L.A., Gonz&#xe1;lez Lama J., Jim&#xe9;nez Garc&#xed;a C., S&#xe1;nchez Montero R., Rider Garrido F. Caracter&#xed;sticas cl&#xed;nico-epidemiol&#xf3;gicas de la infecci&#xf3;n por el virus SARS-CoV-2 en m&#xe9;dicos de familia: Un estudio de casos y controles. Aten. Primaria. 2021;53:101956. doi: 10.1016/j.aprim.2020.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aprim.2020.12.001</ArticleId><ArticleId IdType="pmc">PMC7746083</ArticleId><ArticleId IdType="pubmed">33592533</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rula de Torres L.&#xc1;., Gonz&#xe1;lez-Lama J., Jim&#xe9;nez Garc&#xed;a C., S&#xe1;nchez Montero R., Rider Garrido F., Ortega L&#xf3;pez Y., Pajares Conde D., Ram&#xed;rez Baena M., P&#xe1;rraga Mart&#xed;nez I., Romero-Rodr&#xed;guez E. Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection. Med. Clin. 2021;156:595&#x2013;601. doi: 10.1016/j.medcli.2020.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2020.12.015</ArticleId><ArticleId IdType="pmc">PMC8141902</ArticleId><ArticleId IdType="pubmed">34056110</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W., Ni Z., Hu Y., Liang W., Ou C., He J., Liu L., Shan H., Lei C., Hui D.S.C., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Centros Para el Control y la Prevenci&#xf3;n de Enfermedades  Afecciones Persistentes al COVID-19 y Afecciones Posteriores al COVID-19 2022.  [(accessed on 23 September 2021)]; Available online:  https://espanol.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Soriano J., Murthy S., Marshall J., Relan P., Diaz J. A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. WHO; Geneva, Switzerland: 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>The PHOSP-COVID Collaborative Group Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: A prospective observational study. Lancet. Respir. Med. 2022;10:761&#x2013;775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu&#xed;a Cl&#xed;nica Para la Atenci&#xf3;n al Paciente LONG COVID/COVID Persistente 2021.  [(accessed on 28 September 2021)].  Available online:  https://www.semg.es/index.php/consensos-guias-y-protocolos/363-guia-clinica-para-la-atencion-al-paciente-long-covid-covid-persistente.</Citation></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschtick J.L., Titus A.R., Slocum E., Power L.E., Hirschtick R.E., Elliott M.R., McKane P., Fleischer N.L. Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics. Clin. Infect. Dis. 2021;73:2055&#x2013;2064. doi: 10.1093/cid/ciab408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab408</ArticleId><ArticleId IdType="pmc">PMC8240848</ArticleId><ArticleId IdType="pubmed">34007978</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S., Banasik K., Pedersen O.B., Nissen J., Cantwell L., Schwinn M., Tulstrup M., Westergaard D., Ullum H., Brunak S., et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci. Rep. 2021;11:13153. doi: 10.1038/s41598-021-92045-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Daitch V., Yelin D., Awwad M., Guaraldi G., Mili&#x107; J., Mussini C., Falcone M., Tiseo G., Carrozzi L., Pistelli F., et al. Characteristics of long COVID among older adults: A cross-sectional study. Int. J. Infect. Dis. 2022;125:287&#x2013;293. doi: 10.1016/j.ijid.2022.09.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.09.035</ArticleId><ArticleId IdType="pubmed">36191820</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-las-pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Pellicer-Valero &#xd3;.J., Navarro-Pardo E., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Arias-Naval&#xf3;n J.A., Cigar&#xe1;n-M&#xe9;ndez M., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J. Clin. Med. 2022;11:413. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D., Margalit I., Nehme M., Bordas-Mart&#xed;nez J., Pistelli F., Yahav D., Guessous I., Dur&#xe0;-Miralles X., Carrozzi L., Shapira-Lichter I., et al. Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study. J. Clin. Med. 2022;11:898. doi: 10.3390/jcm11040898.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11040898</ArticleId><ArticleId IdType="pmc">PMC8875229</ArticleId><ArticleId IdType="pubmed">35207171</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A., Ara&#xfa;jo-Ameijeiras A., Fern&#xe1;ndez-Villar A., Crespo M., Poveda E., Cabrera J.J., del Campo V., de Araujo B.G., G&#xf3;mez C., Leiro V., et al. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci. Rep. 2022;12:3369. doi: 10.1038/s41598-022-07414-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07414-x</ArticleId><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C.P.-V.O.J., Navarro-Pardo E.P.-C.D.F.L.L., Guijarro C.M.-G.J.D. Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection as Risk Factor of Long-term Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study. Int. J. Infect. Dis. 2022;116:241&#x2013;244. doi: 10.1016/j.ijid.2022.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.01.007</ArticleId><ArticleId IdType="pmc">PMC8743274</ArticleId><ArticleId IdType="pubmed">35017102</ArticleId></ArticleIdList></Reference><Reference><Citation>Organizaci&#xf3;n Mundial de la Salud  Enfermedad Por Coronavirus (COVID-19): Afecci&#xf3;n Posterior a la COVID-19 2021.  [(accessed on 1 October 2021)].  Available online:  https://www.who.int/es/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition.</Citation></Reference><Reference><Citation>Scientific Advisory Group COVID-19 Scientific Advisory Group Rapid Evidence Report. Updat. Rev. Prolong. symptoms after acute COVID-19 Infect. Alberta Health Services, Physical distancing works. 2021.</Citation></Reference><Reference><Citation>Tleyjeh I.M., Saddik B., Ramakrishnan R.K., AlSwaidan N., AlAnazi A., Alhazmi D., Aloufi A., AlSumait F., Berbari E.F., Halwani R. Long term predictors of breathlessness, exercise intolerance, chronic fatigue and well-being in hospitalized patients with COVID-19: A cohort study with 4 months median follow-up. J. Infect. Public Health. 2022;15:21&#x2013;28. doi: 10.1016/j.jiph.2021.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2021.11.016</ArticleId><ArticleId IdType="pmc">PMC8600938</ArticleId><ArticleId IdType="pubmed">34861604</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministerio de Sanidad  Manejo en Atenci&#xf3;n Primaria y Domiciliaria del COVID-19 2020.  [(accessed on 23 September 2021)].  Available online:  https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Manejo_primaria.pdf.</Citation></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 Long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Risk Factors Associated with Long COVID Syndrome: A Retrospective Study. Iran. J. Med. Sci. 2021;46:428&#x2013;436. doi: 10.30476/IJMS.2021.92080.2326.</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/IJMS.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari N., Khodayari Y., Hosseinian-Far A., Zarei H., Rasoulpoor S., Akbari H., Mohammadi M. Global prevalence of chronic fatigue syndrome among long COVID-19 patients: A systematic review and meta-analysis. Biopsychosoc. Med. 2022;16:21. doi: 10.1186/s13030-022-00250-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13030-022-00250-5</ArticleId><ArticleId IdType="pmc">PMC9589726</ArticleId><ArticleId IdType="pubmed">36274177</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabria M., Garc&#xed;a-S&#xe1;nchez C., Grunden N., Pons C., Arroyo J.A., G&#xf3;mez-Anson B., Est&#xe9;vez Garc&#xed;a M., del C., Belv&#xed;s R., Moroll&#xf3;n N., et al. Post-COVID-19 fatigue: The contribution of cognitive and neuropsychiatric symptoms. J. Neurol. 2022;269:3990&#x2013;3999. doi: 10.1007/s00415-022-11141-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11141-8</ArticleId><ArticleId IdType="pmc">PMC9055007</ArticleId><ArticleId IdType="pubmed">35488918</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins T., Gonevski M., Clark C., Baitule S., Sharma K., Magar A., Patel K., Sankar S., Kyrou I., Ali A., et al. Hyperbaric oxygen therapy for the treatment of long COVID: Early evaluation of a highly promising intervention. Clin. Med. 2021;21:E629&#x2013;E632. doi: 10.7861/clinmed.2021-0462.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C., Bentivegna E., Cho S.J., Harriott A.M., Garc&#xed;a-Azor&#xed;n D., Labastida-Ramirez A., Ornello R., Raffaelli B., Beltr&#xe1;n E.R., Ruscheweyh R., et al. Long COVID headache. J. Headache Pain. 2022;23:93. doi: 10.1186/s10194-022-01450-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Izquierdo M., L&#xe1;inez-Ramos-Bossini A.J., de Alba I.G.F., Ortiz-Gonz&#xe1;lez-Serna R., Serrano-Ortiz &#xc1;., Fern&#xe1;ndez-Mart&#xed;nez N.F., Ruiz-Montero R., Cervilla J.A. Long COVID 12 months after discharge: Persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes-a multicentre cohort study. BMC Med. 2022;20:92. doi: 10.1186/s12916-022-02292-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02292-6</ArticleId><ArticleId IdType="pmc">PMC8863509</ArticleId><ArticleId IdType="pubmed">35193574</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylvester S.V., Rusu R., Chan B., Bellows M., O&#x2019;Keefe C., Nicholson S. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: A review. Curr. Med. Res. Opin. 2022;38:1391&#x2013;1399. doi: 10.1080/03007995.2022.2081454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2081454</ArticleId><ArticleId IdType="pubmed">35726132</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinzon R.T., Wijaya V.O., Al Jody A., Nunsio P.N., Buana R.B. Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis. J. Infect. Public Health. 2022;15:856&#x2013;869. doi: 10.1016/j.jiph.2022.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.06.013</ArticleId><ArticleId IdType="pmc">PMC9221935</ArticleId><ArticleId IdType="pubmed">35785594</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou M.-I., Palaiodimou L., Bakola E., Smyrnis N., Papadopoulou M., Paraskevas G.P., Rizos E., Boutati E., Grigoriadis N., Krogias C. Neurological manifestations of long-COVID syndrome: A narrative review. Ther. Adv. Chronic Dis. 2022;13 doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Chronic long-COVID syndrome: A protracted COVID-19 illness with neurological dysfunctions. CNS Neurosci. Ther. 2021;27:1433&#x2013;1436. doi: 10.1111/cns.13737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13737</ArticleId><ArticleId IdType="pmc">PMC8611765</ArticleId><ArticleId IdType="pubmed">34626096</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M., Elliott J., Chadeau-Hyam M., Riley S., Darzi A., Cooke G., Ward H., Elliott P. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 2022;13:1957. doi: 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Ailshire J., Crimmins E. Long COVID and Symptom Trajectory in a Representative Sample of Americans. Res. Sq. 2022;12:11647. doi: 10.21203/RS.3.RS-1440503/V1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/RS.3.RS-1440503/V1</ArticleId><ArticleId IdType="pmc">PMC9264749</ArticleId><ArticleId IdType="pubmed">35804058</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Yu C., Jing H., Wu X., Novakovic V.A., Xie R., Shi J. Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation. Front. Cell. Infect. Microbiol. 2022;12:861703. doi: 10.3389/fcimb.2022.861703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health. 2022;19:12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. How vaccination affects the risk of Long Covid. Nature. 2021;599:546&#x2013;548. doi: 10.1038/d41586-021-03495-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-03495-2</ArticleId><ArticleId IdType="pubmed">34815580</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J., Vogel G. Vaccines may cause rare, Long Covid-like symptoms. Science. 2022;375:364&#x2013;366. doi: 10.1126/science.ada0536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.ada0536</ArticleId><ArticleId IdType="pubmed">35084966</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. eClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mul&#xe8; G., Augello M., Mondatore D., Allegrini M., Cona A., et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin. Microbiol. Infect. 2022;28:611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>